Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...
Bulletin: ...WINTER WEATHER ADVISORY REMAINS IN EFFECT UNTIL 3 PM EST THIS AFTERNOON... * WHAT...Freezing rain. Additional ice accumulations around a light glaze ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results